Tahir Sheikh

610 total citations
19 papers, 431 citations indexed

About

Tahir Sheikh is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tahir Sheikh has authored 19 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tahir Sheikh's work include Protein Degradation and Inhibitors (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Sarcoma Diagnosis and Treatment (4 papers). Tahir Sheikh is often cited by papers focused on Protein Degradation and Inhibitors (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Sarcoma Diagnosis and Treatment (4 papers). Tahir Sheikh collaborates with scholars based in United States, Pakistan and Russia. Tahir Sheikh's co-authors include Gary K. Schwartz, Archie Tse, Jayasree S. Nair, Katherine G. Rendahl, Samuel McNeely, Sylvia Ma, Yves Pommier, Barbara Hibner, Millicent Embry and Edward J. Moler and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Tahir Sheikh

18 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tahir Sheikh United States 8 335 162 62 48 48 19 431
Michael Grondine United States 8 421 1.3× 265 1.6× 76 1.2× 67 1.4× 63 1.3× 14 544
Akito Nakamura Japan 8 326 1.0× 119 0.7× 58 0.9× 31 0.6× 56 1.2× 13 424
Kazuhiro Ohara Japan 4 346 1.0× 138 0.9× 40 0.6× 45 0.9× 30 0.6× 6 407
Jill Piens United States 4 296 0.9× 214 1.3× 34 0.5× 60 1.3× 29 0.6× 7 395
Hélène Malka-Mahieu France 6 387 1.2× 136 0.8× 29 0.5× 32 0.7× 51 1.1× 10 456
Robert H. Sinnamon United States 6 510 1.5× 141 0.9× 47 0.8× 40 0.8× 36 0.8× 7 566
Martine B.W. Prinsen Netherlands 11 270 0.8× 151 0.9× 98 1.6× 80 1.7× 65 1.4× 19 456
Lora A. Tucker United States 13 326 1.0× 242 1.5× 56 0.9× 84 1.8× 88 1.8× 15 577
Donna-Michelle Smith United Kingdom 9 151 0.5× 213 1.3× 65 1.0× 100 2.1× 57 1.2× 12 363
Edward J. Lewis United Kingdom 5 223 0.7× 150 0.9× 40 0.6× 77 1.6× 15 0.3× 5 360

Countries citing papers authored by Tahir Sheikh

Since Specialization
Citations

This map shows the geographic impact of Tahir Sheikh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tahir Sheikh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tahir Sheikh more than expected).

Fields of papers citing papers by Tahir Sheikh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tahir Sheikh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tahir Sheikh. The network helps show where Tahir Sheikh may publish in the future.

Co-authorship network of co-authors of Tahir Sheikh

This figure shows the co-authorship network connecting the top 25 collaborators of Tahir Sheikh. A scholar is included among the top collaborators of Tahir Sheikh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tahir Sheikh. Tahir Sheikh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Fernández, Iván Sánchez, Marta Amengual‐Gual, Tahir Sheikh, et al.. (2023). Temporal trends in the cost and use of first‐line treatments for infantile epileptic spasms syndrome. Epilepsia. 64(3). 630–640. 3 indexed citations
3.
Musi, Elgilda, Tahir Sheikh, Matthew Ingham, Sminu Bose, & Gary K. Schwartz. (2023). Abstract 6174: ATX-101, a peptide drug targeting PCNA, enhances the effect of gemcitabine in liposarcoma and leiomyosarcoma. Cancer Research. 83(7_Supplement). 6174–6174. 1 indexed citations
4.
Lee, Shing M., Mihaela Druta, Anthony P. Conley, et al.. (2023). ETCTN/NCI 10330: A phase 2 study of belinostat with SGI-110 (guadecitabine) or ASTX727 (decitabine/cedazuridine) for the treatment of unresectable and metastatic conventional chondrosarcoma.. Journal of Clinical Oncology. 41(16_suppl). 11531–11531. 1 indexed citations
5.
Sheikh, Tahir, Xiao Chen, Xinjing Xu, et al.. (2021). Growth Inhibition and Induction of Innate Immune Signaling of Chondrosarcomas with Epigenetic Inhibitors. Molecular Cancer Therapeutics. 20(12). 2362–2371. 15 indexed citations
6.
Oza, Jay, Brittany L. Siontis, Benjamin Powers, et al.. (2021). A phase 2 study of belinostat and SGI-110 (guadecitabine) for the treatment of unresectable and metastatic conventional chondrosarcoma.. Journal of Clinical Oncology. 39(15_suppl). TPS11578–TPS11578. 5 indexed citations
7.
8.
Fayyaz, Ghulam Qadir, Nauman Ahmad Gill, Iftikhar Alam, et al.. (2018). Continuous Versus Interrupted Sutures for Primary Cleft Palate Repair. Plastic & Reconstructive Surgery Global Open. 6(11). e2001–e2001. 6 indexed citations
9.
Sheikh, Tahir, Parag P. Patwardhan, & Gary K. Schwartz. (2018). Abstract A30: Preclinical study of a combination of mocetinostat (HDAC inhibitor) and 5-AZA-dC (decitabine) in chondrosarcoma. Clinical Cancer Research. 24(2_Supplement). A30–A30. 1 indexed citations
10.
Sheikh, Tahir, Parag P. Patwardhan, & Gary K. Schwartz. (2017). Abstract 5066: Combination treatment with SAHA and 5-Azacytidine (Decitabine) induces apoptosis and suppresses tumor growth in preclinical models of chondrosarcoma. Cancer Research. 77(13_Supplement). 5066–5066. 2 indexed citations
11.
Sheikh, Tahir, Parag P. Patwardhan, Serge Cremers, & Gary K. Schwartz. (2017). Targeted inhibition of glutaminase as a potential new approach for the treatment of NF1 associated soft tissue malignancies. Oncotarget. 8(55). 94054–94068. 22 indexed citations
12.
Sheikh, Tahir, Parag P. Patwardhan, & Gary K. Schwartz. (2016). Abstract 19: Neurofibromatosis type 1 (NF1) status determines sensitivity of soft tissue sarcoma and melanoma cell lines to glutaminase inhibitors. Cancer Research. 76(14_Supplement). 19–19. 1 indexed citations
13.
Sheikh, Tahir, Parag P. Patwardhan, Serge Cremers, & Gary K. Schwartz. (2015). Abstract 4450: CB839, an orally bioavailable glutaminase inhibitor, shows potent antitumor activity in vitro against models of soft tissue sarcoma and chondrosarcoma. Cancer Research. 75(15_Supplement). 4450–4450. 2 indexed citations
14.
Nair, Jayasree S., Tahir Sheikh, Alan L. Ho, & Gary K. Schwartz. (2013). PTEN regulates sensitivity of melanoma cells to RO4929097, the γ-secretase inhibitor.. PubMed. 33(4). 1307–16. 28 indexed citations
15.
Miller, Martin L., Evan Molinelli, Jayasree S. Nair, et al.. (2013). Drug Synergy Screen and Network Modeling in Dedifferentiated Liposarcoma Identifies CDK4 and IGF1R as Synergistic Drug Targets. Science Signaling. 6(294). ra85–ra85. 72 indexed citations
16.
McNeely, Samuel, Chiara Conti, Tahir Sheikh, et al.. (2010). Chk1 inhibition after replicative stress activates a double strand break response mediated by ATM and DNA-dependent protein kinase. Cell Cycle. 9(5). 995–1004. 68 indexed citations
17.
Tse, Archie, David S. Klimstra, Mithat Gönen, et al.. (2008). A Phase 1 Dose-Escalation Study of Irinotecan in Combination with 17-Allylamino-17-Demethoxygeldanamycin in Patients with Solid Tumors. Clinical Cancer Research. 14(20). 6704–6711. 49 indexed citations
18.
19.
Tse, Archie, Katherine G. Rendahl, Tahir Sheikh, et al.. (2007). CHIR-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons In vitro and In vivo. Clinical Cancer Research. 13(2). 591–602. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Grondine Breakdown of academic impact, for papers by Akito Nakamura Breakdown of academic impact, for papers by Kazuhiro Ohara Breakdown of academic impact, for papers by Jill Piens Breakdown of academic impact, for papers by Hélène Malka-Mahieu Breakdown of academic impact, for papers by Robert H. Sinnamon Breakdown of academic impact, for papers by Martine B.W. Prinsen Breakdown of academic impact, for papers by Lora A. Tucker Breakdown of academic impact, for papers by Donna-Michelle Smith Breakdown of academic impact, for papers by Edward J. Lewis
Rankless by CCL
2026